BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17498638)

  • 1. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.
    Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM
    Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni.
    Liang YS; Wang W; Dai JR; Li HJ; Tao YH; Zhang JF; Li W; Zhu YC; Coles GC; Doenhoff MJ
    J Helminthol; 2010 Jun; 84(2):202-7. PubMed ID: 19765323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
    Sabra AN; Botros SS
    J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
    da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
    Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    Ann Trop Med Parasitol; 2001 Oct; 95(7):715-23. PubMed ID: 11784425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.
    Fallon PG; Sturrock RF; Niang AC; Doenhoff MJ
    Am J Trop Med Hyg; 1995 Jul; 53(1):61-2. PubMed ID: 7625534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
    Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
    Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
    Fallon PG; Doenhoff MJ
    Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails.
    Couto FF; Coelho PM; Araújo N; Kusel JR; Katz N; Jannotti-Passos LK; Mattos AC
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):153-7. PubMed ID: 21537673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
    Alwan SN; Taylor AB; Rhodes J; Tidwell M; McHardy SF; LoVerde PT
    PLoS Pathog; 2023 Jul; 19(7):e1011018. PubMed ID: 37428793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R; Pinto PL; de Sant'Ana EJ; Moreira AA; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):201-3. PubMed ID: 3135570
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
    Barakat R; El Morshedy H
    Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
    Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
    J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of chemotherapy on the Schistosoma mansoni eggs].
    dos Reis MG; Andrade ZA
    Mem Inst Oswaldo Cruz; 1987; 82(2):161-5. PubMed ID: 3147355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of UV-irradiation, gamma irradiation and praziquantel on infected Biomphalaria alexandrina snails.
    Mostafa BB; Gad HS
    J Egypt Soc Parasitol; 1997 Apr; 27(1):35-46. PubMed ID: 9097525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.
    Botros SS; El-Din SH; El-Lakkany NM; Sabra AN; Ebeid FA
    J Parasitol; 2006 Dec; 92(6):1344-9. PubMed ID: 17304818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.